July 8 (Reuters) – Amgen Inc’s biosimilar form of
AbbVie Inc’s Humira arthritis drug, the world’s
top-selling medicine, is similarly potent and safe as the
original product, according to a…
The post UPDATE 1-FDA staff says Amgen biosimilar ‘highly similar’ to Abbvie’s Humira appeared first on NASDAQ.